Your browser does not support the video tag.
Skip to content
home button
  • Resources
    • By Topic
      • Access to Clinical Trials
      • Artificial Intelligence
      • Clinical Trials Landscape
      • Data Collecting + Reporting
      • Ensuring Quality
      • Innovative Trials
      • Patient Engagement
      • Recruitment
      • Regulatory Submissions + Approvals
      • Safety
      • Site Planning
    • By Trial Stage
      • Study Design
        • Innovative Trials
        • Patient Group Engagement
        • Recruitment
      • Study Operations
        • Data Collecting
        • Regulatory Submissions + Approvals
        • Site Planning
  • Case Studies
  • About CTTI
  • Newsroom
  • Membership
  • Annual Report
connect with us
Signup for our Newsletter
  • About CTTI
  • Newsroom
  • Membership
  • Annual Report
Search

CTTI

Clinical Trials Transformation Initiative

Author: Hannah Faulkner

NIH Collaboratory Grand Rounds Webinar on CTTI’s DMC Project

Posted on November 11, 2016January 31, 2025 by Hannah Faulkner

NIH Collaboratory Grand Rounds Webinar on CTTI’s DMC Project

Posted in Data Monitoring Committees, Data Monitoring Committees, Ensuring Quality, Related: Data Monitoring Committees, Safety, Study Operations, Webinars

Patient and physician attitudes regarding risk and benefit in streamlined development programmes for antibacterial drugs: a qualitative analysis

Posted on November 10, 2016January 29, 2025 by Hannah Faulkner

Patient and physician attitudes regarding risk and benefit in streamlined development programmes for antibacterial drugs: a qualitative analysis

Posted in ABDD Unmet Need, Antibacterial Drug Development-Unmet Need, Ensuring Quality, Publications, Regulatory Submissions + Approvals, Related: ABDD Unmet Need, Safety, Study Design

Clinical Trials Transformation Initiative Releases Recommendations to Enhance the Feasibility of Developing New Antibacterial Drugs

Posted on August 1, 2016January 15, 2025 by Hannah Faulkner

Clinical Trials Transformation Initiative Releases Recommendations to Enhance the Feasibility of Developing New Antibacterial Drugs

Posted in ABDD Streamlining HABP/VABP, Antibacterial Drug Development-Streamlining HABP/VABP Trials, Improving Population Health, Press Releases, Related: ABDD Streamlining HABP/VABP

Supplement: Facilitating Antibacterial Drug Development in a Time of Great Need

Posted on August 1, 2016November 21, 2024 by Hannah Faulkner

Supplement: Facilitating Antibacterial Drug Development in a Time of Great Need

Posted in Antibacterial Drug Development-Streamlining HABP/VABP Trials, Improving Population Health, Publications, Related: ABDD Streamlining HABP/VABP

Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team

Posted on August 1, 2016January 15, 2025 by Hannah Faulkner

Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team

Posted in ABDD Streamlining HABP/VABP, Antibacterial Drug Development-Streamlining HABP/VABP Trials, Publications, Related: ABDD Streamlining HABP/VABP

How Public–Private Collaborations Are Driving Solutions to the Antibacterial Drug Development Crisis

Posted on August 1, 2016January 15, 2025 by Hannah Faulkner

How Public–Private Collaborations Are Driving Solutions to the Antibacterial Drug Development Crisis

Posted in ABDD Streamlining HABP/VABP, Antibacterial Drug Development-Streamlining HABP/VABP Trials, Publications, Related: ABDD Streamlining HABP/VABP

Facilitating Antibacterial Drug Development in a Time of Great Need

Posted on August 1, 2016January 15, 2025 by Hannah Faulkner

Facilitating Antibacterial Drug Development in a Time of Great Need

Posted in ABDD Streamlining HABP/VABP, Antibacterial Drug Development-Streamlining HABP/VABP Trials, Publications, Related: ABDD Streamlining HABP/VABP

Streamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Trials: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team

Posted on August 1, 2016January 15, 2025 by Hannah Faulkner

Streamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Trials: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team

Posted in ABDD Streamlining HABP/VABP, Antibacterial Drug Development-Streamlining HABP/VABP Trials, Publications, Related: ABDD Streamlining HABP/VABP

Participant Summary: IMPACT-AF: Formative Research Summary

Posted on July 5, 2016February 5, 2025 by Hannah Faulkner

Participant Summary: IMPACT-AF: Formative Research Summary

Posted in Data Collecting and Reporting, Electronic Healthcare Data, Electronic Healthcare Data, Innovative Trials, Related: Electronic Healthcare Data, Resources, Study Design, Study Operations

Paving the way to a more effective informed consent process: Recommendations from the Clinical Trials Transformation Initiative

Posted on June 17, 2016February 5, 2025 by Hannah Faulkner

Paving the way to a more effective informed consent process: Recommendations from the Clinical Trials Transformation Initiative

Posted in Informed Consent, Informed Consent, Publications, Related: Informed Consent, Safety, Study Design, Study Operations

Posts navigation

← Older posts
Newer posts →
 

DISCLAIMER: CTTI encourages the use of all materials listed on this site in the pursuit of improving the clinical trials enterprise. Our recommendations, tools, meeting summaries, and more are available to the public for free. We do ask that you acknowledge the source whenever using or referencing CTTI materials. Read our Citation Policy. 

  • About
  • Newsroom
  • Membership
  • Case Studies
  • Contact Us
  • Access to Clinical Trials
  • Artificial Intelligence
  • Clinical Trials Landscape
  • Data Collecting + Reporting
  • Ensuring Quality
  • Innovative Trials
  • Informed Consent
  • Patient Group Engagement
  • Real-World Data
  • Recruitment
  • Regulatory Submissions + Approvals
  • Safety + Protection
  • Site Planning
Sign up for our Newsletter
Log in

© Clinical Trials Transformation Initiative © 2026

terms of use

privacy statement

WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.